By Admin at 20 Nov 2015
Researchers at The Institute of Cancer Research analyzed DNA from more than 25,000 men and uncovered four new genetic variants (or genetic markers) associated with an increased risk of testicular cancer. Testing for these four variants combined with the 21 previously identified genetic variants identified men at a 10-fold higher risk of developing testicular cancer.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial